DK1614690T3 - Peptidfragment af LYVE-1 og antistof mod dette - Google Patents
Peptidfragment af LYVE-1 og antistof mod detteInfo
- Publication number
- DK1614690T3 DK1614690T3 DK04719660.5T DK04719660T DK1614690T3 DK 1614690 T3 DK1614690 T3 DK 1614690T3 DK 04719660 T DK04719660 T DK 04719660T DK 1614690 T3 DK1614690 T3 DK 1614690T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptide fragment
- antibody
- lyve
- amino acid
- terminal
- Prior art date
Links
- 108010033276 Peptide Fragments Proteins 0.000 title abstract 5
- 102000007079 Peptide Fragments Human genes 0.000 title abstract 5
- 102100026849 Lymphatic vessel endothelial hyaluronic acid receptor 1 Human genes 0.000 title abstract 2
- 101710178181 Lymphatic vessel endothelial hyaluronic acid receptor 1 Proteins 0.000 title abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 2
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 abstract 1
- QOXDAWODGSIDDI-GUBZILKMSA-N Glu-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N QOXDAWODGSIDDI-GUBZILKMSA-N 0.000 abstract 1
- CRJZZXMAADSBBQ-SRVKXCTJSA-N Ser-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO CRJZZXMAADSBBQ-SRVKXCTJSA-N 0.000 abstract 1
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 abstract 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 abstract 1
- 210000001365 lymphatic vessel Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003070568 | 2003-03-14 | ||
| PCT/JP2004/003231 WO2004081035A1 (ja) | 2003-03-14 | 2004-03-11 | Ｌｙｖｅ－１のペプチドフラグメント及びそれに対する抗体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1614690T3 true DK1614690T3 (da) | 2010-12-20 |
Family
ID=32984660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04719660.5T DK1614690T3 (da) | 2003-03-14 | 2004-03-11 | Peptidfragment af LYVE-1 og antistof mod dette |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7339022B2 (da) |
| EP (1) | EP1614690B1 (da) |
| JP (1) | JP3899362B2 (da) |
| KR (1) | KR20050108390A (da) |
| CN (1) | CN1761679A (da) |
| AT (1) | ATE482973T1 (da) |
| AU (1) | AU2004220209A1 (da) |
| CA (1) | CA2518548C (da) |
| DE (1) | DE602004029345D1 (da) |
| DK (1) | DK1614690T3 (da) |
| WO (1) | WO2004081035A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009125831A1 (ja) * | 2008-04-11 | 2009-10-15 | 有限会社スリーピー | Ｎｋ４に対するモノクローナル抗体 |
| GB201901559D0 (en) | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
| CN115531558B (zh) * | 2022-09-16 | 2024-07-26 | 华中科技大学 | 一种动物肝脏淋巴管系统的标记和三维图谱成像方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231000A (en) * | 1987-10-08 | 1993-07-27 | The Mclean Hospital | Antibodies to A4 amyloid peptide |
| WO1998006839A1 (en) * | 1996-07-15 | 1998-02-19 | Human Genome Sciences, Inc. | Cd44-like protein |
| US7160985B2 (en) | 1997-10-29 | 2007-01-09 | Genentech, Inc. | Pro180 polypeptide |
| US6368794B1 (en) * | 1999-01-15 | 2002-04-09 | Incyte Genomics, Inc. | Detection of altered expression of genes regulating cell proliferation |
| US20040018594A1 (en) * | 2001-05-03 | 2004-01-29 | Alsobrook John P. | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| WO2003006104A2 (en) | 2001-07-12 | 2003-01-23 | Ludwig Institute For Cancer Research | Lymphatic endothelial cells materials and methods |
-
2004
- 2004-03-11 CA CA2518548A patent/CA2518548C/en not_active Expired - Lifetime
- 2004-03-11 KR KR1020057017105A patent/KR20050108390A/ko not_active Withdrawn
- 2004-03-11 JP JP2005503584A patent/JP3899362B2/ja not_active Expired - Lifetime
- 2004-03-11 DE DE602004029345T patent/DE602004029345D1/de not_active Expired - Lifetime
- 2004-03-11 WO PCT/JP2004/003231 patent/WO2004081035A1/ja not_active Ceased
- 2004-03-11 US US10/548,495 patent/US7339022B2/en not_active Expired - Lifetime
- 2004-03-11 EP EP04719660A patent/EP1614690B1/en not_active Expired - Lifetime
- 2004-03-11 DK DK04719660.5T patent/DK1614690T3/da active
- 2004-03-11 AU AU2004220209A patent/AU2004220209A1/en not_active Abandoned
- 2004-03-11 CN CNA2004800069340A patent/CN1761679A/zh active Pending
- 2004-03-11 AT AT04719660T patent/ATE482973T1/de not_active IP Right Cessation
-
2008
- 2008-01-10 US US12/008,279 patent/US7858751B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1614690B1 (en) | 2010-09-29 |
| DE602004029345D1 (de) | 2010-11-11 |
| AU2004220209A1 (en) | 2004-09-23 |
| US20090053202A1 (en) | 2009-02-26 |
| CA2518548A1 (en) | 2004-09-23 |
| US7858751B2 (en) | 2010-12-28 |
| JPWO2004081035A1 (ja) | 2006-08-24 |
| EP1614690A1 (en) | 2006-01-11 |
| EP1614690A4 (en) | 2006-07-26 |
| US7339022B2 (en) | 2008-03-04 |
| ATE482973T1 (de) | 2010-10-15 |
| JP3899362B2 (ja) | 2007-03-28 |
| US20060127396A1 (en) | 2006-06-15 |
| CN1761679A (zh) | 2006-04-19 |
| CA2518548C (en) | 2011-12-06 |
| WO2004081035A1 (ja) | 2004-09-23 |
| KR20050108390A (ko) | 2005-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| DE60232577D1 (de) | Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential | |
| ATE387629T1 (de) | Gemeinsame epitope von antigenen aus einer multigen-familie | |
| ATE417595T1 (de) | Keratin-bindende polypeptide | |
| ATE355368T1 (de) | Nucleinsäure bindende polypeptide gekennzeichnet durch flexible linker verbundene nucleinsäuredomäne | |
| WO2005051998A3 (en) | Antibodies binding to a c-terminal fragment of apolipoprotein e | |
| DK1346034T3 (da) | von Willebrand-faktor (vWF) spaltende protease-polypeptid, nukleinsyre kodende for polypeptidet og anvendelse af polypeptidet | |
| CY1114893T1 (el) | Παραγωγη ανθρωπινης γλυκοσερεμπροσιδασης υψηλης μαννοζης σε φυτικη καλλιεργεια | |
| DK2327719T3 (da) | Hybrid- og tandemekspression af neisseria-proteiner | |
| WO2002018443A3 (en) | A recombinant monoclonal antibody to phosphotyrosine-containing proteins | |
| NZ547629A (en) | Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb | |
| DK2020604T3 (da) | Ligand for den G-proteinkoblede receptor FPRL2 | |
| EP1982992A4 (en) | HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR | |
| DK1614690T3 (da) | Peptidfragment af LYVE-1 og antistof mod dette | |
| TW200505943A (en) | Polypeptide | |
| ATE413452T1 (de) | Polypeptid | |
| ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
| JP2005535281A5 (da) | ||
| EP1842911A4 (en) | HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS | |
| DE60221273D1 (de) | Verfahren zur steigerung der expression von menschlichen tnf-rezeptor | |
| SE0101519D0 (sv) | Nucleic ACID | |
| ATE466876T1 (de) | Immunogene konstrukte | |
| WO2004056316A3 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
| ATE511516T1 (de) | Gpr-146-rezeptor | |
| WO2005062871A3 (en) | Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays |